J&J Could Explore Potential $2B Sale of Sterilization Products Division Post author:Sam Post published:February 19, 2018 Post category:BioPharma Life sciences giant Johnson & Johnson may be shopping around its sterilization products division. Source: BioSpace You Might Also Like Alzheon Launches IPO to Fund Alzheimer's Drug March 18, 2018 Commonwealth Diagnostics Announces U.S. Launch And New Global Developments August 30, 2017 Proteostasis and Roche Diagnostics Ink Huge Space in New Boston Hub October 8, 2017